Hemolysis of patients with end stage renal disease evaluated by erythrocyte creatine
Not Applicable
- Conditions
- End stage renal disease
- Registration Number
- JPRN-UMIN000036418
- Lead Sponsor
- Kansai Medical University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 69
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignant tumor Patients with auto immune hemolytic anemia Patients who received transfusion within 3 months Patients with myelodysplastic syndromes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of hemolysis between hemodialysis and peritoneal dialysis
- Secondary Outcome Measures
Name Time Method Comparison of long-term prognosis with all-cause death between end stage renal disease participants with and without hemolysis